U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 021871
Company: TEVA BRANDED PHARM
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
LOESTRIN 24 FE ETHINYL ESTRADIOL; NORETHINDRONE ACETATE 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET;ORAL Discontinued None Yes No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
02/17/2006 ORIG-1 Approval Type 3 - New Dosage Form STANDARD Label (PDF)
Letter (PDF)
Review
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021871lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021871s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021871TOC.cfm
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
04/29/2022 SUPPL-12 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021871s012lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/021871Orig1s012ltr.pdf
09/02/2021 SUPPL-10 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021871s010lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/021871Orig1s010ltr.pdf
08/09/2017 SUPPL-8 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021871s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/021871Orig1s008ltr.pdf
04/19/2016 SUPPL-6 Manufacturing (CMC)

Label is not available on this site.

05/01/2013 SUPPL-4 Manufacturing (CMC)

Label is not available on this site.

09/10/2010 SUPPL-2 Manufacturing (CMC)-Facility

Label is not available on this site.

08/22/2016 SUPPL-1 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021871s001lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/021871Orig1s001ltr.pdf
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
04/29/2022 SUPPL-12 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021871s012lbl.pdf
09/02/2021 SUPPL-10 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021871s010lbl.pdf
08/09/2017 SUPPL-8 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021871s008lbl.pdf
08/22/2016 SUPPL-1 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021871s001lbl.pdf
02/17/2006 ORIG-1 Approval Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021871lbl.pdf
Back to Top